Diabetes Care Devices - Sudan | Statista Market Forecast

In Sudan, the revenue in the Diabetes Care Devices market market is projected to reach US$33.94m in 2024.
This revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 9.21%, leading to a market volume of US$52.73m by 2029.
In a global context, the United States will generate the highest revenue, amounting to US$11.71bn in 2024.
In Sudan, the increasing prevalence of diabetes is driving demand for advanced diabetes care devices, highlighting the urgent need for improved healthcare infrastructure and accessible technologies.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Sudan is witnessing moderate growth, influenced by factors such as increasing diabetes prevalence, rising healthcare investments, and growing awareness about diabetes management solutions among the population.

Customer preferences: In Sudan, there is a noticeable shift towards diabetes care devices that emphasize user-friendly technology and affordability, as individuals seek solutions that fit their lifestyles. The growing prevalence of diabetes, along with increasing health awareness, has led to a demand for innovative self-monitoring tools and mobile applications that facilitate easier disease management. Additionally, cultural factors, such as community support and education programs, are influencing preferences for devices that promote collaboration with healthcare providers, enhancing overall patient engagement and adherence to treatment regimens.

Trends in the market: In Sudan, the Diabetes Care Devices Market is experiencing a surge in demand for innovative self-monitoring technologies, driven by the rising prevalence of diabetes and heightened health awareness among the population. Users are increasingly favoring affordable, user-friendly devices that integrate seamlessly into daily life, including mobile applications that aid in disease management. Additionally, community support initiatives and educational programs are fostering a collaborative approach to healthcare, enhancing patient engagement. This trend signifies a shift towards personalized care, prompting industry stakeholders to invest in technology that promotes accessibility and adherence to treatment plans.

Local special circumstances: In Sudan, the Diabetes Care Devices Market is shaped by unique geographical and cultural factors, including a diverse climate that impacts healthcare access in remote areas. The lack of robust healthcare infrastructure necessitates low-cost, portable diabetes management devices that can be used without extensive training. Additionally, cultural attitudes towards traditional medicine influence patient preferences, making community-based education essential for acceptance of modern technologies. Regulatory challenges also affect market entry, with a need for compliance with local standards, driving companies to adapt their products to meet specific regional needs.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Sudan is significantly influenced by macroeconomic factors, including national economic stability, foreign investment, and healthcare spending. The overall economic health of the country, characterized by fluctuations in GDP and inflation rates, directly impacts consumer purchasing power and healthcare funding. Fiscal policies aimed at improving healthcare access may enhance the market, while limited public health budgets can hinder the adoption of advanced diabetes care technologies. Furthermore, global economic trends, such as the rising demand for affordable healthcare solutions and technological innovations, play a crucial role in shaping local market dynamics, fostering the development of cost-effective diabetes management devices tailored to the Sudanese context.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.